Raj Rajnarayanan Profile picture
Oct 3, 2022 15 tweets 15 min read Read on X
#COVID19 #VariantDashboard - #UnitedStates

TOP lineages (15-DAY TRENDS):

23.2% BA.5.2.1
13.5% BA.5.2
10.6% BA.5.1
10.0% BA.4.6
4.0% BF.10
3.3% BA.5.5
2.8% BA.5.6
2.4% BA.5.2.9
2.2% BF.7
2.0% BA.5

Tracker: tinyurl.com/mryj4uu7
#OmicronUpdates 10/02/22
1/n
Top circulating lineages (#15DayTrends)

83.7%BA.5*
10% BA.4.6*
2.2%BF.7*
1.5%BA.4*
1.2%BA.2.75*
0.5%BQ.1*
0.3%BA.2.3.30*
0.4%BQ.1.1*

2/n Image
.@CDCgov updated variant proportions estimates on 9/30/2022



3/n
Lineages to watch

BQ.1*/BQ1.1*
BA.2.75.2* ( & CA.1*)
XBB - Recombinant of BJ.1 and BM.1.1.1
BA.2.3.20



4/n
#NorthCarolina, #Massachusetts #California, #NewYork are BA.4.6* (Spike R346T) hotspots

#15DayTrends

5/n Image
Tracking BA.2.75* (#Centaurus) and XBB (#Gryphon) over time in #USA

Closely following several newly designated BA.2.75* sub-lineages

Global Tracker: public.tableau.com/app/profile/ra…

6/n Image
BA.2.75* family of lineages and XBB (recombinant of BJ.1/BM.1.1.1) are highly immune evasive while retaining their host receptor binding affinity!

Their biggest competition will be from BQ* lineages.

Global Tracker: public.tableau.com/app/profile/ra…

7/n Image
Updates from #LineageWatchTeam's @GenSpectrum
#Collection24 maintained by @siamosolocani /
@Asinickle1

>> All eyes on BQ.1*/BQ.1.1*, BA.2.3.20 and BA.2.75* lineages <<

Collection24: cov-spectrum.org/collections/24…

Tracker: public.tableau.com/shared/QFBZWNX…

(#15DayTrends - #USA)

8/n Image
#Hospital #Capacity - (by State/Division)

All hospitalizations not just COVID-19

public.tableau.com/app/profile/ra…

9/n
#COVID19 #Hospitalizations in the #UnitedStates

Please get #boosted (especially > 50 yr old and immune compromised) and #MaskUP!

Hospital Tracker (by States, by age group): public.tableau.com/app/profile/ra…

10/n
Closely watching #COVID19 #Hospitalizations in > 50 years old in #USA

Get #Boosted ASAP!

11/n Image
Closely watching #Pediatric #COVID19 #Hospitalizations in #USA

12/n Image
#COVID19 #Cases and #Deaths - US States
- @CDCgov data

Tracker: public.tableau.com/app/profile/ra…

13/n
Status of the latest #COVID19 Wave in #NewYork #BellwetherState

Top circulating variants - BA.5.2.1 (21%), BA.5.2 (15%), BA.4.6 (13.3%)

Other key lineages
BF.7 (2.3%)
BQ.1* (1.7%)
BQ.1.1* (0.6%)
BA.2.75.2* (0.6%)

Don't let your guard down!

14/n ImageImage
Status of the latest #COVID19 Wave in #Massachusetts

Top circulating variants - BA.5.2.1 (18.3%), BA.5.2 (16.4%), BA.5.1 (12.8%), BA.4.6 (11.7%)

Other key lineages
BE.1.1* (2.7%)
BF.11 (2.2%)
BQ.1* (0.8%)
BA.2.75.2* (0.5%)

Don't let your guard down!

14/n ImageImage

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Raj Rajnarayanan

Raj Rajnarayanan Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @RajlabN

Oct 20
Tracking #SARSCoV2 #Lineages - Globally |10/19/24

Top lineages -#30DayTrends #G30

KP.3.1.1 (41.9%)
XEC (10.5%)👀
KP.2.3 (3.1%)
MC.13 (3.1%)
MC.16 (2.6%)
MC.1 (2.5%)
KP.3.3 (2.3%)
LB.1.3.1 (1.9%)
MC.10 (1.7%)
MC.11 (1.4%)
XEC.2 (1.3%)👀



1/n public.tableau.com/app/profile/ra…Image
Granular details #Global #30DayTrends

KP.3.1.1* is still the top circulating group of lineages in the world.

This analysis includes #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 09/19/2024 (11,851sequences)

2/n Image
@GISAID Thanks to all the countries that are supporting #SARSCoV2 testing and rapidly submitting sequences to @GISAID

Top submitters #Canada #USA #France #UK #Netherlands #Sweden #Spain #Japan #Italy
#Denmark #Australia #Ireland #Singapore
#China #NewZealand #Slovenia #Germany

3/n Image
Read 4 tweets
Sep 27
#SARSCoV2 #VariantProportions - #USA |09/27/24

@CDCgov #Nowcast 2-Week estimates

KP.3.1.1 (JN.1.11.1.3.1.1) is still the top circulating lineage in the USA

🚨XEC makes an entry @ 5.7%



1/n covid.cdc.gov/covid-data-tra…
Image
Reliable nowcast estimates are available only for HHS regions 2, 3, 4, 5, 7 and 9

Other regions did not sequence enough

2/n Image
KP.3.1.1* group of lineages

In the @CDCgov nowcast chart....
KP.3.1.1* is not further separated in to MC.1-MC.16 sub-lineages

3/n Image
Read 6 tweets
Sep 8
Tracking #SARSCoV2 #Lineages - Globally |09/07/24

Top lineages -#30DayTrends

KP.3.1.1 (37.1%)
KP.2.3 (9%)
KP.3.3 (5.7%)
KP.3.1 (2.9%)
XDV.1 (2.9%)
KP.1.1.3 (2.7%)
LB.1 (2.3%)
LB.1.3 (2.1%)
KP.2.2 (2%)
---
XEC (1.4%)👀

Track #G30 :

1/n public.tableau.com/app/profile/ra…
Image
Granular details #Global #30DayTrends

KP.3.1.1* is still the top circulating group of lineages in the world.

This analysis includes #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 08/08/2024 (12,884 sequences)

2/n Image
@GISAID Thanks to all the countries that are supporting #SARSCoV2 testing and rapidly submitting sequences to @GISAID

Top submitters #USA #Canada #UK #Sweden #Japan
#China #Spain #Australia #Germany #Denmark #SouthKorea #France #Singapore #NewZealand #Ireland #Italy #Netherlands Image
Read 16 tweets
Sep 1
What the XEC!

Recombinant #SARSCoV2 lineage #XEC (recombinant of KS.1.1/KP.3.3) has the potential to outcompete other circulating lineages in #USA (and other countries)

More data is needed to provide a reliable growth advantage estimates
Image
#VariantHunters are closely monitoring XEC.1 with signature mutations Spike K182R & ORF1a:L4182F
XEC.1 was proposed by #VariantHunter @siamosolocani

github.com/sars-cov-2-var…
Read 5 tweets
Aug 25
Tracking #SARSCoV2 #Lineages - Globally |08/25/24

Top lineages -#30DayTrends

KP.3.1.1 (30.1%)👀
KP.2.3 (11%)
KP.3.3 (7.1%)
KP.3.1 (4.2%)
LB.1.7 (2.7%)
KP.2 (2.5%)
LB.1 (2.5%)
KP.1.1.3 (2.5%)
KP.2.2 (2.2%)
---
XEC (0.4%)

Track #G30 :

1/n public.tableau.com/app/profile/ra…
Image
Granular details #Global #30DayTrends

KP.3.1.1* is the top circulating group of lineages in the world. This analysis includes #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 07/25/2024 (14,688 sequences)

2/n Image
@GISAID Thanks to all the countries that are still supporting #SARSCoV2 testing and rapidly submitting sequences to @GISAID

Top submitters: #USA #Canada #UK #Japan #Spain
#Sweden #Netherlands #SouthKorea #Denmark #Israel #Ireland #Singapore #Australia #China #Germany #Italy #France Image
Read 17 tweets
Aug 11
Tracking #SARSCoV2 #Lineages - Globally |08/10/24

Top lineages -#30DayTrends

KP.3.1.1 (24.2%)👀
KP.2.3 (9.5%)
KP.3.3 (8.4%)
KP.3.1 (5.9%)
LB.1 (2.5%)
KP.2.2 (2.4%)
KP.2 (2.4%)
KP.3 (2.3%)
LB.1.7 (2.3%)
KP.3.2.3 (2.2%)

Track #G30 :

1/n public.tableau.com/app/profile/ra…
Image
Granular details #Global #30DayTrends

KP.3.1.1 is the top circulating lineage in the world. This analysis includes #SARSCoV2 sequences submitted to @GISAID with sample collection dates on or after 07/11/2024 (15,325 sequences)

2/n Image
@GISAID Thanks to all the countries that are still supporting #SARSCoV2 testing and rapidly submitting sequences to @GISAID

Top submitters: #USA #Canada #UK #Japan #Spain
#France #China #Netherlands #Israel #Ireland
#Australia #Singapore #Denmark #Italy #Sweden #Germany #Guatemala Image
Read 21 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(